Snowball logo
logo
2161

JBM (Healthcare) Limited

2161 โ€ข HK
HK$1.635HK$0.00ย  (0%)
Estimate
Beta
0.184
Growth
Revenue, YoY
25.93%
Net income, YoY
26.58%
FCF, YoY
-64.89%
Forecast
P/E (FWD)
5.5
EPS (FWD)
0.295
Dividends
Dividend yield
8.99%
Annual payout
HK$0.15
Next ex. div date
September 7, 26
Payout
63.39%
Dividend growth streak
3 y
Div.rating
About the company
Ticker
2161
ISIN
KYG1090B1077
Country
Hong Kong
Sector (GICS)
Healthcare
JBM (Healthcare) Limited, an investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, Singapore, and internationally. It operates through Branded Medicines, Proprietary Chinese Medicines, and Health and Wellness Products segments. The Branded Medicines segment develops, manufactures, and distributes branded medicines with chemical compounds as active ingredients. The Proprietary Chinese Medicines segment develops, manufactures, and distributes registered Chinese medicines composed of Chinese herbal medicines. The Health and Wellness Products segment distributes and sells supplements, medical consumables, and other non-pharmaceutical products for the general health and wellness of consumers. The company also offers consumer healthcare and proprietary Chinese medicines, such as over-the-counter medicines, and CCMG products. It is also involved in the manufactures, trading, wholesaling, and retailing of Chinese medicines; trading of medical supplies and pharmaceutical products; and sale of healthcare and herbal products. The company was incorporated in 2020 and is headquartered in Kwun Tong, Hong Kong.

Frequently asked questions

What sector does JBM (Healthcare) Limited (2161) operate in?

JBM (Healthcare) Limited belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is JBM (Healthcare) Limited (2161) current stock price?

As of the latest data, JBM (Healthcare) Limited stock price is HK$1.64, with a previous close of HK$1.64.

What is JBM (Healthcare) Limited (2161) current market capitalization?

JBM (Healthcare) Limited market cap is approximately 1.34 billion.

What is JBM (Healthcare) Limited (2161) EBITDA?

JBM (Healthcare) Limited EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 136.23 million.

Does JBM (Healthcare) Limited (2161) pay dividends?

Yes. JBM (Healthcare) Limited pays semiannual dividends with an annualized yield of 8.99% and an estimated annual payout of HK$0.15 per share.

When is the next ex-dividend date for JBM (Healthcare) Limited (2161)?

The next ex-dividend date is scheduled for September 07, 2026.

What is JBM (Healthcare) Limited (2161) beta (volatility) score?

JBM (Healthcare) Limited has a beta of 0.184, indicating lower volatility than the overall market.